Title

Depatuxizumab-mafodotin in EGFR-amplified newly diagnosed glioblastoma: a phase III randomized clinical trial

Publication Date

2022

Content Type

Article

PubMed ID:

35849035

Additional Authors:

Additional authors and institutional affiliations

This document is currently not available here.

Share

COinS